Tenon Medical Secures $2.87M via Warrant Inducement, Issues 858K New Warrants

summarizeSummary

Tenon Medical raised $2.87M by inducing exercise of existing warrants, issuing 858,269 new five-year warrants at $5.02 in return. Capital extends runway for the distressed company but adds future dilution overhang.

check_boxKey Events · Financing and Capital Events · TNON

• Warrant Inducement Raises $2.87M

  Armistice Capital exercised 572,179 existing Series A warrants at $5.02/share, generating approximately $2,872,339 in gross cash proceeds for working capital.

• 858K New Warrants Issued

  In exchange, Tenon issued 858,269 new Series B warrants (150% of exercised shares) at $5.02 exercise price, exercisable for five years — creating future dilution if the stock recovers above $5.02.

• Financial Advisor Compensation

  WallachBeth Capital receives a 7% cash fee on gross proceeds (~$201K) plus up to $65,000 in expense reimbursement.

• Resale Registration Commitment

  Company must file a resale registration statement for the new warrant shares within 30 days and use commercially reasonable efforts to have it effective within 60-90 days.

auto_awesomeAnalysis · TNON · Industrial Applications And Services

Tenon Medical induced Armistice Capital to exercise 572,179 existing warrants at $5.02 per share, generating approximately $2.87 million in gross proceeds. In exchange, the company issued 858,269 new Series B warrants — 150% of the exercised shares — also at $5.02, exercisable for five years. The deal provides immediate working capital for a company with a going-concern warning and less than 12 months of cash runway, but the new warrants create additional future dilution overhang. The exercise price sits above the current $4.04 share price, meaning the new warrants are out-of-the-money today, but the 150% coverage ratio means any future share price recovery above $5.02 would trigger significant dilution.